0001104659-15-051249.txt : 20150715 0001104659-15-051249.hdr.sgml : 20150715 20150715153823 ACCESSION NUMBER: 0001104659-15-051249 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150630 FILED AS OF DATE: 20150715 DATE AS OF CHANGE: 20150715 EFFECTIVENESS DATE: 20150715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versant Venture Management, LLC CENTRAL INDEX KEY: 0001560009 IRS NUMBER: 954767945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16849 FILM NUMBER: 15989291 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001560009 XXXXXXXX 06-30-2015 06-30-2015 false Versant Venture Management, LLC
One Sansome Street, Suite 3630 San Francisco CA 94104
13F HOLDINGS REPORT 028-16849 N
Robin L. Praeger Managing Director, Versant Venture Management, LLC (415) 801-8100 /s/ Robin L. Praeger San Francisco CA 07-14-2015 0 5 78844234 false
INFORMATION TABLE 2 a15-15704_1informationtable.xml INFORMATION TABLE Clovis Oncology, Inc. Common Stock 189464100 35803718 407416 SH OTR 0 407416 0 Five Prime Therapeutics, Inc. Common Stock 33830X104 27129055 1092152 SH OTR 0 1092152 0 CymaBay Therapeutics, Inc. Common Stock 23257D103 2820736 1048601 SH OTR 0 1048601 0 Achaogen, Inc. Common Stock 004449104 7725346 1281152 SH OTR 0 1281152 0 Biotie Therapies Corp. ADS 09074D103 5365379 268672 SH OTR 0 268672 0